InMed Pharmaceuticals Inc.
INM | NASDAQ
$13.21
-$4.29 (-24.53%)
At close: Nov 5, 2026, 4:00 PM ET
$13.53
+$0.32 (+2.42%)
After-hours:
Nov 5, 2026, 4:28 PM ET
TTM Period Ending | Q1 2027 Sep 30, 2026 | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -20.67B | -18.34B | -3.76B | -3.76B | -8.89M | -8.16M | -8.31M | -7.91M | -6.82M | -7.68M | -6.08M | -6.35M | -6.97M | -7.95M | -15.48M | -16.96M | -19.14M | -18.6M | -13.99M | -13.61M | -12.2M |
Depreciation & Amortization | 221.59M | 708.36K | 579.24K | 575.37K | 546.43K | 534.73K | 555.5K | 576.61K | 600.13K | 604.52K | 603.63K | 595.57K | 590.32K | 589.46K | 583.01K | 583.18K | 573.88K | 479.81K | 374.6K | 286.78K | 276.81K |
Stock-Based Compensation | 193.88M | 177.53M | 45.53M | 45.54M | 110.55K | 119.31K | 131.53K | 146.38K | 141.49K | 137.71K | 139.24K | 134.29K | 186.67K | 278.16K | 414.56K | 559.29K | 703.43K | 697.89K | 741.86K | 754.07K | 662.68K |
Other Working Capital | 213.56K | 13.47K | -689.53K | -608.25K | -54.18K | -505.63K | 331.88K | 115.71K | -607.23K | -203.37K | -908.75K | -721.75K | -794.42K | -576.64K | -951.32K | -2.66M | -1.15M | -1.18M | -30.36K | -203.34K | -334.91K |
Other Non-Cash Items | 19.1B | 18.15B | 3.71B | 3.71B | 145.28K | 78.32K | 97.53K | 72.93K | 253.32K | 248.03K | -239.99K | -286.13K | -356.18K | 223.81K | 5.65M | 5.86M | 5.65M | 5.05M | -174.58K | -362.12K | 119.97K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 94.95K | 94.95K | 94.95K | 94.95K | n/a | n/a | n/a | n/a | 1.26K | 1.26K | 713 | -309.1K |
Change in Working Capital | -1.08M | -2.05M | -1.27M | -818.71K | -91.76K | -337.17K | 509.32K | -174.92K | -785.89K | -364.61K | -1.18M | -519.77K | -769.8K | -453.43K | -1.55M | -3.9M | -2.47M | -2.71M | -417.53K | -60.31K | -316.6K |
Operating Cash Flow | -1.15B | -10.14M | -9.01M | -8.91M | -8.18M | -7.77M | -7.02M | -7.29M | -6.61M | -6.95M | -6.66M | -6.38M | -7.28M | -7.36M | -10.61M | -14.23M | -15.05M | -15.45M | -13.66M | -13M | -11.76M |
Capital Expenditures | 9.49 | 9.49 | 9.49 | 5.49 | n/a | n/a | 92 | 92 | -9.13K | -9.13K | -168.82K | -168.82K | -159.6K | -159.6K | 81.55 | -3.23K | -38.78K | -38.78K | -40.65K | -37.35K | -1.8K |
Cash Acquisitions | 2.42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 490.38K | n/a | n/a | 90.78K | -399.59K | 90.78K | 90.78K | n/a | n/a | n/a |
Purchase of Investments | -70.65M | -70.67M | -25.18M | -25.17M | -41.9K | -42.27K | -39.61K | -44.77K | -41.93K | -41.92K | -84.51K | -63.31K | -63.48K | -42.16K | -421.36K | -421.36K | -421.36K | -421.36K | n/a | n/a | n/a |
Sales Maturities Of Investments | 70.65M | 70.67M | 25.18M | 25.17M | 41.9K | 42.27K | 39.61K | 44.77K | 41.93K | 41.92K | 84.51K | 63.31K | 63.48K | 42.16K | -90.97K | -91.55K | n/a | n/a | 90.97K | 91.55K | n/a |
Other Investing Acitivies | 2.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 118.45K | -500.49K | -510.11K | -510.11K | -926.45K | -307.51K | -47.88K | -297.88K | n/a | n/a | -250K |
Investing Cash Flow | 2.42M | n/a | n/a | n/a | n/a | n/a | 87.86 | 87.86 | -9.13K | -9.13K | -50.37K | -178.93K | -669.71K | -669.71K | -1.35M | -1.22M | -417.23K | -667.23K | 50.31K | 54.2K | -251.8K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 393.68K | 368.73K | -288.33K | -288.33K | -682.01K | -657.06K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -431.66M | -431.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 471.62M | 431.66M | 4.41M | 4.39M | 4.33M | 4.14M | -220.56K | -205.46K | -147.82K | 44K | n/a | n/a | 571.26K | n/a | n/a | n/a | -571.26K | -1.12M | -1.12M | -1.53M | -2.88M |
Financial Cash Flow | 40.23M | 40.49K | 8.22M | 10.9M | 11.24M | 12.27M | 4.1M | 1.21M | 5.49M | 4.65M | 4.78M | 4.73M | 5.43M | 10.86M | 15.72M | 15.64M | 9.49M | 14.94M | 10.01M | 14.15M | 23.87M |
Net Cash Flow | -1.11B | -10.45M | -1.09M | 1.96M | 3.06M | 4.5M | -2.92M | -6.12M | -1.16M | -2.34M | -2M | -1.92M | -2.61M | 2.74M | 3.71M | 172.61K | -5.99M | -1.19M | -3.56M | 1.26M | 12.38M |
Free Cash Flow | -1.15B | -10.14M | -9.01M | -8.91M | -8.18M | -7.77M | -7.02M | -7.29M | -6.62M | -6.96M | -6.83M | -6.55M | -7.44M | -7.52M | -10.61M | -14.24M | -15.09M | -15.49M | -13.7M | -13.03M | -11.76M |
Adj. Free Cash Flow | -1.34B | -187.67M | -54.54M | -54.44M | -8.29M | -7.89M | -7.15M | -7.44M | -6.76M | -7.1M | -6.97M | -6.69M | -7.62M | -7.8M | -11.03M | -14.79M | -15.79M | -16.19M | -14.44M | -13.79M | -12.43M |
Maintenance CapEx | 14.98 | 14.98 | 14.98 | 10.98 | n/a | n/a | 92 | 92 | 92 | 92 | n/a | 9.52 | 9.52 | 9.52 | 163.11 | 153.59 | 153.59 | 153.59 | -1.8K | -1.8K | -1.8K |
Growth CapEx | -5.49 | -5.49 | -5.49 | -5.49 | n/a | n/a | n/a | n/a | -9.22K | -9.22K | -168.82K | -168.83K | -159.61K | -159.61K | -81.55 | -3.38K | -38.93K | -38.93K | -38.85K | -35.55K | n/a |
Owner Earnings | -1.15B | -10.14M | -9.01M | -8.91M | -8.18M | -7.77M | -7.02M | -7.29M | -6.61M | -6.95M | -6.66M | -6.38M | -7.28M | -7.36M | -10.61M | -14.23M | -15.05M | -15.45M | -13.66M | -13M | -11.76M |
Add to Watchlist
Select watchlists to add or remove INM